{"id":"placebo-for-celecoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo effect (symptom improvement without active drug)"}]},"_chembl":{"chemblId":"CHEMBL118","moleculeType":"Small molecule","molecularWeight":"381.38"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to establish the efficacy of an active drug by comparison. Any observed effects in placebo groups are attributed to the placebo effect, natural disease progression, or regression to the mean rather than direct drug action. In this case, the placebo is being used as a control arm in a Phase 3 trial comparing celecoxib (an active COX-2 inhibitor) to an inactive comparator.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:58.662Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trial for celecoxib efficacy evaluation"}]},"trialDetails":[{"nctId":"NCT05077332","phase":"PHASE2","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","status":"COMPLETED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT06505187","phase":"PHASE2","title":"Celecoxib for ENT Pain Management","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2025-02-28","conditions":"Parotidectomy","enrollment":84},{"nctId":"NCT05658887","phase":"PHASE4","title":"Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery","status":"COMPLETED","sponsor":"Joseph Kowalski","startDate":"2023-01-01","conditions":"Pelvic Organ Prolapse, Perioperative/Postoperative Complications","enrollment":110},{"nctId":"NCT06159114","phase":"PHASE4","title":"Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS","status":"COMPLETED","sponsor":"Xintian Pharmaceutical","startDate":"2023-12-19","conditions":"Chronic Prostatitis","enrollment":246},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT06722534","phase":"NA","title":"Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2025-02-01","conditions":"Peutz-Jeghers Syndrome, Celecoxib, Small Bowel Polyp","enrollment":80},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT04162873","phase":"PHASE2","title":"Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer","status":"TERMINATED","sponsor":"University of Utah","startDate":"2019-11-27","conditions":"Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Nasal Cavity and Paranasal Sinus Carcinoma","enrollment":13},{"nctId":"NCT06316843","phase":"PHASE2","title":"Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2","status":"COMPLETED","sponsor":"Bateman Horne Center","startDate":"2023-10-15","conditions":"Long COVID, PASC Post Acute Sequelae of COVID 19","enrollment":59},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT03084536","phase":"PHASE2","title":"PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-06-07","conditions":"Breast Cancer, Breast Cancer Female, Cancer of Breast","enrollment":134},{"nctId":"NCT04176419","phase":"PHASE3","title":"Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2020-01-17","conditions":"Postoperative Pain Control, Opioid Consumption","enrollment":30},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT04765644","phase":"PHASE4","title":"Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-06-10","conditions":"Healthy","enrollment":44},{"nctId":"NCT05644301","phase":"PHASE3","title":"INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2023-09-21","conditions":"Major Depressive Disorder, Inflammation","enrollment":240},{"nctId":"NCT05077969","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","status":"TERMINATED","sponsor":"Leidos Life Sciences","startDate":"2021-12-29","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":4},{"nctId":"NCT01479829","phase":"PHASE4","title":"Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression","status":"COMPLETED","sponsor":"Loyola University","startDate":"2011-03-23","conditions":"Bipolar Depression","enrollment":100},{"nctId":"NCT04790812","phase":"PHASE4","title":"Preemptive Analgesia With Celecoxib for Acute Dental Pain Management","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-04-22","conditions":"Pain, Postoperative","enrollment":65},{"nctId":"NCT05288374","phase":"PHASE4","title":"Celecoxib in Postoperative Analgesia for Radius Fracture Surgery","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2022-02-10","conditions":"Pain, Postoperative","enrollment":42},{"nctId":"NCT02502006","phase":"PHASE1","title":"Variability in Response to Non-steroidal Anti-inflammatory Drugs","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2015-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT02688400","phase":"PHASE3","title":"Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis","status":"COMPLETED","sponsor":"TRB Chemedica International SA","startDate":"2016-05","conditions":"Osteoarthritis, Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT03949673","phase":"PHASE2","title":"Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-04-08","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":23},{"nctId":"NCT05085574","phase":"PHASE2","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","status":"WITHDRAWN","sponsor":"Leidos Life Sciences","startDate":"2023-02-07","conditions":"2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease","enrollment":""},{"nctId":"NCT02389465","phase":"PHASE4","title":"Stress and Inflammation in Late-Life Depression","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-08","conditions":"Depression, Inflammation","enrollment":119},{"nctId":"NCT04648540","phase":"EARLY_PHASE1","title":"Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT05555823","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib","status":"COMPLETED","sponsor":"Atriva Therapeutics GmbH","startDate":"2022-06-23","conditions":"Healthy","enrollment":96},{"nctId":"NCT03304379","phase":"PHASE3","title":"Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-10-26","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":1650},{"nctId":"NCT01765296","phase":"PHASE3","title":"Phase III Study of CG100649 in Osteoarthritis Patients","status":"COMPLETED","sponsor":"CrystalGenomics, Inc.","startDate":"2013-03","conditions":"Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee","enrollment":362},{"nctId":"NCT04673578","phase":"PHASE2","title":"Adjunctive Celecoxib in Childhood-onset OCD Study","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2021-06-01","conditions":"Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder","enrollment":80},{"nctId":"NCT05638893","phase":"PHASE2, PHASE3","title":"Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-02-01","conditions":"Knee Osteoarthritis","enrollment":50},{"nctId":"NCT05362851","phase":"PHASE3","title":"Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee","status":"UNKNOWN","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2021-11-11","conditions":"Osteoarthritis, Knee","enrollment":692},{"nctId":"NCT05324995","phase":"PHASE2","title":"Peri-Articular-Multimodal Drug and Oral Celecoxib in Management of Postoperative Pain of Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2021-01-01","conditions":"Postoperative Pain, Total Knee Arthroplasty","enrollment":146},{"nctId":"NCT01150045","phase":"PHASE3","title":"Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery","status":"UNKNOWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-06","conditions":"Colorectal Cancer","enrollment":2527},{"nctId":"NCT04505657","phase":"NA","title":"Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":150},{"nctId":"NCT00809354","phase":"PHASE3","title":"Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip","status":"TERMINATED","sponsor":"Pfizer","startDate":"2009-02-12","conditions":"Osteoarthritis, Arthritis","enrollment":2720},{"nctId":"NCT03850587","phase":"PHASE2","title":"Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Yooyoung Pharmaceutical Co., Ltd.","startDate":"2018-08-30","conditions":"Osteoarthritis, Knee","enrollment":261},{"nctId":"NCT00139776","phase":"PHASE4","title":"Study Of \"Continuous Use\" Of Celecoxib Vs. \"Usual or Intermittent Use\"","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-07","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip","enrollment":875},{"nctId":"NCT00359151","phase":"PHASE4","title":"Celebrex Total Knee Arthroplasty Study","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-11","conditions":"Osteoarthritis, Pain","enrollment":22},{"nctId":"NCT00346216","phase":"PHASE4","title":"Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-10-04","conditions":"Arthritis, Rheumatoid","enrollment":24081},{"nctId":"NCT00585312","phase":"PHASE3","title":"Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-09","conditions":"Adenomatous Polyposis Coli","enrollment":106},{"nctId":"NCT00630929","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-01","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00633386","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-02","conditions":"Arthroscopy","enrollment":200},{"nctId":"NCT00633438","phase":"PHASE4","title":"Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-01","conditions":"Arthroscopy","enrollment":204},{"nctId":"NCT00620867","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2002-10","conditions":"Osteoarthritis, Knee","enrollment":393},{"nctId":"NCT00640627","phase":"PHASE4","title":"Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":380},{"nctId":"NCT00638807","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-12","conditions":"Osteoarthritis, Knee","enrollment":388},{"nctId":"NCT00643799","phase":"PHASE4","title":"Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-03","conditions":"Osteoarthritis, Knee","enrollment":586},{"nctId":"NCT01062113","phase":"PHASE2","title":"Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-04","conditions":"Pain","enrollment":255},{"nctId":"NCT00994461","phase":"PHASE4","title":"Study Of Celecoxib In Healthy Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-11","conditions":"Healthy Volunteers","enrollment":190},{"nctId":"NCT00640809","phase":"PHASE4","title":"Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-10","conditions":"Bowel Diseases, Inflammatory","enrollment":408},{"nctId":"NCT01838044","phase":"PHASE4","title":"Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-10","conditions":"Chronic Low Back Pain With a Neuropathic Component","enrollment":180},{"nctId":"NCT04718649","phase":"NA","title":"Effectiveness and Safety of Celecoxib (Celebrex 200 mg) Combined With Joins in the Treatment of Degenerative Knee Osteoarthritis: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2021-01","conditions":"Osteoarthritis","enrollment":216},{"nctId":"NCT03464552","phase":"PHASE4","title":"Celecoxib in Colposcopic Directed Biopsy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-04-15","conditions":"Colposcopy","enrollment":170},{"nctId":"NCT00033371","phase":"PHASE2","title":"Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-12-13","conditions":"Colorectal Cancer, Familial Adenomatous Polyposis","enrollment":205},{"nctId":"NCT02725411","phase":"PHASE3","title":"Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-05-26","conditions":"Low Back Pain","enrollment":277},{"nctId":"NCT00062179","phase":"PHASE2","title":"Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-03","conditions":"Lung Cancer","enrollment":7},{"nctId":"NCT02429427","phase":"PHASE3","title":"European Celecoxib Trial in Primary Breast Cancer","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2005-12","conditions":"Breast Cancer","enrollment":2639},{"nctId":"NCT03570554","phase":"PHASE2","title":"A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-29","conditions":"Osteoarthritis, Knee","enrollment":41},{"nctId":"NCT02934191","phase":"PHASE2","title":"Celecoxib After Tonsillectomy","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2016-06","conditions":"Tonsillectomy","enrollment":172},{"nctId":"NCT00009230","phase":"PHASE3","title":"Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2000-06","conditions":"Memory Disorders","enrollment":""},{"nctId":"NCT02780323","phase":"PHASE4","title":"Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2015-11-02","conditions":"Rheumatoid Arthritis","enrollment":119},{"nctId":"NCT02528188","phase":"PHASE3","title":"Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee","status":"COMPLETED","sponsor":"Pfizer","startDate":"2015-07-21","conditions":"Chronic Pain, Osteoarthritis, Hip, Osteoarthritis, Knee","enrollment":3021},{"nctId":"NCT04082715","phase":"PHASE2","title":"Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity","status":"WITHDRAWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2019-10","conditions":"Chronic Back Pain","enrollment":""},{"nctId":"NCT02979197","phase":"PHASE3","title":"Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives","status":"COMPLETED","sponsor":"Kitov Pharma Ltd","startDate":"2016-11-03","conditions":"Hypertension","enrollment":105},{"nctId":"NCT02108366","phase":"PHASE3","title":"Treatment of Severe Influenza A Infection","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2014-03","conditions":"Influenza, Human","enrollment":107},{"nctId":"NCT02779166","phase":"NA","title":"Evaluation of Perioperative Celecoxib for Hip Arthroscopy","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2012-08","conditions":"Hip Labral Tears","enrollment":98},{"nctId":"NCT02192190","phase":"PHASE2","title":"A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2014-07","conditions":"Osteoarthritis, Knee","enrollment":268},{"nctId":"NCT04020588","phase":"PHASE4","title":"Anti-inflammatories and Adolescent Schizophrenia","status":"UNKNOWN","sponsor":"Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico","startDate":"2019-02-25","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT01768520","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2012-07-02","conditions":"Knee Osteoarthritis","enrollment":338},{"nctId":"NCT01632566","phase":"PHASE1","title":"A Multiple-dose Study of LY3031207 in Healthy Participants","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2012-06","conditions":"Healthy Volunteers","enrollment":39},{"nctId":"NCT01968070","phase":"PHASE1","title":"A Study of LY3127760 in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-10","conditions":"Healthy Volunteers","enrollment":80},{"nctId":"NCT02362529","phase":"EARLY_PHASE1","title":"Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":115},{"nctId":"NCT02987920","phase":"PHASE4","title":"Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2017-01","conditions":"Pain, Postoperative","enrollment":23},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT03880916","phase":"NA","title":"Effects of Duloxetine on Postoperative Wound Complication of Total Knee Arthroplasty (TKA) in Central Sensitization Patients","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2019-03-30","conditions":"Osteoarthritis, Knee","enrollment":80},{"nctId":"NCT00022399","phase":"PHASE2","title":"Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2002-04-25","conditions":"Prostate Cancer","enrollment":73},{"nctId":"NCT03108482","phase":"PHASE3","title":"Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.","status":"COMPLETED","sponsor":"Esteve Pharmaceuticals, S.A.","startDate":"2017-03-14","conditions":"Acute Post-surgical Pain","enrollment":637},{"nctId":"NCT01849055","phase":"PHASE1","title":"A Multiple Dose Study of LY3023703 in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-05","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT00685568","phase":"PHASE1","title":"Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-11-21","conditions":"Colorectal Cancer, Precancerous Condition","enrollment":22},{"nctId":"NCT02172040","phase":"PHASE3","title":"Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy","status":"COMPLETED","sponsor":"Kitov Pharmaceuticals, Ltd.","startDate":"2014-06-26","conditions":"Hypertension","enrollment":152},{"nctId":"NCT01323595","phase":"NA","title":"Effectiveness of Celecoxib After Surgical Sperm Retrieval","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2011-01","conditions":"Pain","enrollment":78},{"nctId":"NCT00088972","phase":"PHASE2","title":"S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women","status":"TERMINATED","sponsor":"SWOG Cancer Research Network","startDate":"2004-11","conditions":"Breast Cancer","enrollment":8},{"nctId":"NCT03404479","phase":"PHASE4","title":"Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA","status":"UNKNOWN","sponsor":"Whan-Seok Choi","startDate":"2018-01-25","conditions":"Knee Osteoarthritis","enrollment":90},{"nctId":"NCT01695226","phase":"PHASE2","title":"Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2004-02","conditions":"Breast Neoplasms, Breast Cancer","enrollment":""},{"nctId":"NCT03391570","phase":"NA","title":"Comparing Postoperative Pain Following COX-2 and Prostanoids Expression","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2017-10-17","conditions":"Female Genital Disease","enrollment":60},{"nctId":"NCT00081263","phase":"PHASE2","title":"Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia","status":"COMPLETED","sponsor":"Gynecologic Oncology Group","startDate":"2005-06","conditions":"Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Stage 0 Cervical Cancer","enrollment":130},{"nctId":"NCT02301234","phase":"PHASE3","title":"Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-03-25","conditions":"Osteoarthritis, Pain","enrollment":111},{"nctId":"NCT00679614","phase":"PHASE3","title":"Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2007-12-17","conditions":"Hip Arthroplasty, Knee Arthroplasty, Spinal Anesthesia","enrollment":45},{"nctId":"NCT01769625","phase":"PHASE1, PHASE2","title":"Changes in Biomarkers Using Prostaglandin Inhibitors","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2009-01","conditions":"Biomarker Change Linked to Breast Cancer","enrollment":31},{"nctId":"NCT01425476","phase":"PHASE1, PHASE2","title":"Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2008-07","conditions":"Breast Cancer","enrollment":45},{"nctId":"NCT00582660","phase":"PHASE2","title":"Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2001-12","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":40},{"nctId":"NCT02711579","phase":"PHASE1","title":"Impact of Celecoxib on Electrophysiological Property in Brain of Healthy Volunteer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-05","conditions":"Electrophysiologic Property of Brain","enrollment":40},{"nctId":"NCT00571701","phase":"PHASE2","title":"Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2008-02","conditions":"Recurrent Respiratory Papillomatosis","enrollment":50},{"nctId":"NCT02840162","phase":"PHASE2","title":"Pre-Prostatectomy Celecoxib or Placebo","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2001-05","conditions":"Adenocarcinoma of the Prostate, Prostate Cancer","enrollment":34},{"nctId":"NCT00583453","phase":"PHASE2","title":"Celecoxib as a Post-tonsillectomy Pain Medication","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2007-10","conditions":"Tonsillitis","enrollment":18},{"nctId":"NCT02079727","phase":"PHASE3","title":"Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-06-12","conditions":"Knee Osteoarthritis","enrollment":604},{"nctId":"NCT01858571","phase":"PHASE3","title":"Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2013-10","conditions":"Malignant Childhood Neoplasm","enrollment":108},{"nctId":"NCT00153660","phase":"PHASE3","title":"Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2005-06","conditions":"Arthritis, Cardiovascular Diseases, Cerebrovascular Disorders","enrollment":514},{"nctId":"NCT00099047","phase":"PHASE2","title":"Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-11","conditions":"Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for celecoxib","genericName":"Placebo for celecoxib","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 clinical trial for celecoxib efficacy evaluation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}